Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death - Normandie Université Access content directly
Journal Articles Cancers Year : 2021

Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death

Abstract

Multiple myeloma (MM) is a common hematological disease characterized by the accumulation of clonal malignant plasma cells in the bone marrow. Over the past two decades, new therapeutic strategies have significantly improved the treatment outcome and patients survival. Nevertheless, most MM patients relapse underlying the need of new therapeutic approaches. Plasma cells are prone to produce large amounts of immunoglobulins causing the production of intracellular ROS. Although adapted to high level of ROS, MM cells die when exposed to drugs increasing ROS production either directly or by inhibiting antioxidant enzymes. In this review, we discuss the efficacy of ROS-generating drugs for inducing MM cell death and counteracting acquired drug resistance specifically toward proteasome inhibitors.
Fichier principal
Vignette du fichier
Caillot Cancers 2021.pdf (1.15 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03231403 , version 1 (20-05-2021)

Identifiers

Cite

Mélody Caillot, Hassan Dakik, Frédéric Mazurier, Brigitte Sola. Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death. Cancers, 2021, 13 (10), pp.2411. ⟨10.3390/cancers13102411⟩. ⟨hal-03231403⟩
42 View
181 Download

Altmetric

Share

Gmail Facebook X LinkedIn More